Answers are grounded in this paper and cite their sources.
Patients who stopped mepolizumab had an increase in exacerbations and reduced asthma control versus those who continued.
No takes yet. Share an insight, caveat, or question.
Moore et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: